News

Brain-activated CAR-T cells eliminate aggressive childhood brain tumors in mice

Researchers at the University of California, San Francisco, have developed an engineered immune-cell therapy that activates specifically after reaching the brain. In two mouse models, these B-SYNC CAR-T cells completely eliminated diffuse midline glioma (DMG), an aggressive childhood brain cancer that is almost always fatal within a year.

The approach is designed to keep the therapeutic cells inactive until they enter the brain, where they switch on and attack the tumor. This targeted strategy could potentially reduce damage to healthy tissues elsewhere in the body.

The findings are preclinical: the reported results come from mouse models, and further testing would be needed to determine whether the treatment is safe and effective in people.

Sources